US EditionPublished • loading... • Updated
Parkinson’s research collaboration targets lysosome function
Summary by Parkinson's News Today
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Parkinson’s research collaboration targets lysosome function
Mair Therapeutics is collaborating with Radboud University in the Netherlands to advance Parkinson’s disease research by developing small molecules designed to target TMEM175, a protein that genetic studies have linked to Parkinson’s risk. “Parkinson’s disease remains one of the most pressing medical challenges of our time,” Vasily Kazey, PhD, Mair’s CEO, said in a company press release. “We are excited to collaborate with Radboud University, wh…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
